US2002136757A1PendingUtilityA1
Methods and devices for preventing transmission of sexually transmitted diseases
Priority: Jan 28, 2000Filed: Sep 24, 2001Published: Sep 26, 2002
Est. expiryJan 28, 2020(expired)· nominal 20-yr term from priority
A61K 31/14A61K 9/0034
45
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides methods for preventing the transmission of HIV, methods for prophylaxis of HIV transmission and methods for reducing the risk of HIV transmission vaginally or rectally using compositions having at least one of polyquaternium, glycerin, methylparaben or proplyparaben. The invention further provides methods for inhibiting the transmission of a sexually transmitted disease using the compositions. Additionally, the invention provides combinations of compositions and devices used with such methods.
Claims
exact text as granted — not AI-modifiedWe claim:
1 . A method for preventing the transmission of HIV vaginally or rectally comprising, contacting a bodily fluid suspected of containing HIV with an aqueous composition having at least one component selected from the group consisting of polyquaternium, glycerin and a preservative system.
2 . The method of claim 1 , wherein the preservative system comprises methylparaben and propylparaben.
3 . The method of claim 1 , wherein the bodily fluid is semen.
4 . The method of claim 1 , further comprising placing an effective amount of the composition before or after sexual contact has begun on a penis or in a vagina or rectum.
5 . The method of claim 4 , wherein the composition is placed in the vagina or rectum using an applicator.
6 . The method of claim 4 , wherein an effective amount is at least 0.5 ml.
7 . The method of claim 4 , wherein the composition is placed within one hour of the commencement of sexual contact.
8 . The method of claim 1 , wherein the composition is combined with a device selected from the group consisting of a suppository, condom, sponge or other barrier device.
9 . The method of claim 1 , wherein the composition is selected from the group consisting of AstroGlide® and Vagisil®.
10 . A method for prophylaxis of HIV transmission vaginally or rectally comprising, contacting a bodily fluid suspected of containing HIV with a composition having at least one component selected from the group consisting of polyquaternium, glycerin and a preservative system.
11 . The method of claim 10 , wherein the preservative system comprises methylparaben and propylparaben.
12 . The method of claim 10 , wherein the bodily fluid is semen.
13 . The method of claim 10 , further comprising placing an effective amount of the composition before or after sexual contact has begun on a penis or in a vagina or rectum.
14 . The method of claim 13 , wherein the composition is placed in the vagina or rectum using an applicator.
15 . The method of claim 13 , wherein an effective amount is at least 0.5 ml.
16 . The method of claim 13 , wherein the composition is placed in the vagina or rectum within one hour of the commencement of sexual contact.
17 . The method of claim 10 , wherein said composition is combined with a device selected from the group consisting of a suppository, condom, sponge or other barrier device.
18 . The method of claim 10 , wherein the composition is selected from the group consisting of AstroGlide® and Vagisil®.
19 . A method for reducing the risk of transmission of HIV vaginally or rectally comprising, contacting a bodily fluid suspected of containing HIV with a composition having at least one component selected from the group consisting of polyquaternium, glycerin and a preservative system.
20 . The method of claim 19 , wherein the preservative system comprises methylparaben and propylparaben.
21 . The method of claim 19 , wherein the bodily fluid is semen.
22 . The method of claim 19 , further comprising placing an effective amount of the composition before or after sexual contact has begun on a penis or in a vagina or rectum.
23 . The method of claim 22 , wherein the composition is placed in the vagina or rectum using an applicator.
24 . The method of claim 22 , wherein an effective amount is at least 0.5 ml.
25 . The method of claim 22 , wherein the composition is placed in the vagina or rectum within one hour of the commencement of sexual contact.
26 . The method of claim 19 , wherein said composition is combined with a device selected from the group consisting of a suppository, condom, sponge or other barrier device.
27 . The method of claim 19 , wherein the composition is selected from the group consisting of AstroGlide® and Vagisil®.
28 . A method for inhibiting the transmission of a sexually transmitted disease caused by an agent present in a bodily fluid, comprising placing a composition having at least one component selected from the group consisting of polyquaternium, glycerin, and a preservative system in a vagina, rectum, condom, sponge or on some other barrier device that can be inserted into a vagina or rectum.
29 . The method of claim 28 wherein the preservative system comprises methylparaben and propylparaben.
30 . The method of claim 28 , wherein the agent is HIV.
31 . The method of claim 28 , wherein the bodily fluid is semen.
32 . The method of claim 28 , wherein the composition is placed within one hour after the deposition of the bodily fluid.Join the waitlist — get patent alerts
Track US2002136757A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.